NeuroTronik
About:
Neuro Tronik develops a medical device as an alternative for the drugs used currently to treat heart failures.
Top Investors: Boston Scientific, Hatteras Venture Partners, Sovereign’s Capital, Mountain Group Capital, MedTech Innovator
Description:
NeuroTronik, spun out of medical technology incubator Synecor, is developing a medical device that could take the place of drugs currently used to heart failure. Read more about the company's technology,
Total Funding Amount:
$36.6M
Headquarters Location:
Chapel Hill, North Carolina, United States
Founded Date:
2012-01-01
Contact Email:
fred.mccoy(AT)neurotronik.ie
Founders:
William Starling
Number of Employees:
Last Funding Date:
2019-12-24
IPO Status:
Private
Industries:
© 2025 bioDAO.ai